- $812.75m
- $1.24bn
- $1.46bn
- 92
- 98
- 75
- 99
R2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,275 | 1,146 | 683 | 1,190 | 1,465 |
Cost of Revenue | |||||
Gross Profit | 307 | 381 | 56.4 | 392 | 678 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,384 | 1,076 | 868 | 944 | 933 |
Operating Profit | -109 | 70.2 | -185 | 246 | 532 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -307 | -18.7 | -282 | 211 | 530 |
Provision for Income Taxes | |||||
Net Income After Taxes | -325 | -24.3 | -277 | 210 | 517 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -311 | -82.9 | 7.81 | 78.4 | 151 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -311 | -82.9 | 7.81 | 78.4 | 151 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.59 | -1.22 | -0.406 | 0.254 | 1.47 |